Robotic Surgery for Early-Stage Lung Cancer
Part of Cancer, Lungs & breathing clinical trials.
This study is testing a new robotic surgical system for removing lung cancer in its early stage. It aims to see if the technique is safe and effective for people with stage I non-small cell lung cancer who need a lobectomy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosis of non-small cell lung cancer (NSCLC)
- Clinical stage I disease (according to 9th TNM edition)
- Planned or completed lobectomy with radical lymph node dissection
- Willingness to participate and provide consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether robotic-assisted surgery for lung cancer is safe and effective in elderly patients. It may be a good option if you are older and able to undergo surgery.
This study compares two types of minimally invasive surgery—robotic-assisted (da Vinci) and VATS—for people with early-stage non-small cell lung cancer. The goal is to see which approach might work better and help patients recover faster.
This study compares two types of minimally invasive lung surgery for early-stage lung cancer. One method uses a robotic arm, the other uses a small camera and long instruments through small cuts. The goal is to see which one gives better results for removing the cancer.
This study compares two different robotic surgery methods for removing early-stage lung cancer. If you are scheduled for robotic surgery, this trial will help doctors learn if a fully robotic approach is better than one where the surgeon assists the robot.
This trial studies a new surgical robot that uses only one small opening in the chest to remove a lung segment or lobe. It aims to see if the robot is safe and effective for patients who need this type of surgery.
This trial compares robotic surgery and video-assisted surgery for removing part of the lung (lobectomy or segmentectomy). It may help determine which approach is safer or works better for patients who can safely tolerate minimally invasive surgery.
Hear when a new Lung Cancer (NSCLC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.